Illumina 8-K Signals Executive/Compensation Change on Jan 4, 2024
Ticker: ILMN · Form: 8-K · Filed: Jan 4, 2024 · CIK: 1110803
| Field | Detail |
|---|---|
| Company | Illumina, INC. (ILMN) |
| Form Type | 8-K |
| Filed Date | Jan 4, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-change, compensation, corporate-governance
TL;DR
**Illumina filed an 8-K on Jan 4, 2024, indicating a significant executive or compensation change.**
AI Summary
Illumina, Inc. filed an 8-K on January 4, 2024, to report an event that occurred on the same date. This filing indicates a change in leadership or executive compensation, specifically under Item 5.02, which covers the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.' While the specific details of the change are not provided in this excerpt, investors should pay attention as changes in key personnel or their compensation can signal shifts in company strategy or financial health, potentially impacting stock performance.
Why It Matters
Changes in executive leadership or compensation can significantly influence a company's direction and financial stability, directly affecting investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — The filing indicates a change in leadership or compensation, which can introduce uncertainty regarding future company performance and strategy.
Analyst Insight
A smart investor would monitor subsequent filings or company announcements for specific details regarding the executive or compensation changes mentioned in this 8-K, as these details will clarify the potential impact on Illumina's future performance.
Key Players & Entities
- Illumina, Inc. (company) — the registrant filing the 8-K
- January 4, 2024 (date) — date of earliest event reported and filing date
- 001-35406 (other) — Commission File Number for Illumina
- Delaware (other) — State of incorporation for Illumina
- 33-0804655 (other) — I.R.S. Employer Identification No. for Illumina
- 5200 Illumina Way, San Diego, CA 92122 (other) — Address of principal executive offices for Illumina
- 858-202-4500 (other) — Registrant’s telephone number
- ILMN (other) — Trading Symbol for Illumina Common Stock
- NASDAQ (other) — Exchange on which Illumina Common Stock is registered
FAQ
What is the specific item number under which Illumina, Inc. filed this 8-K?
Illumina, Inc. filed this 8-K under Item 5.02, which covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers'.
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was January 4, 2024.
What is Illumina, Inc.'s trading symbol and on which exchange is its common stock registered?
Illumina, Inc.'s trading symbol is ILMN, and its common stock is registered on NASDAQ.
What is the address of Illumina, Inc.'s principal executive offices?
The address of Illumina, Inc.'s principal executive offices is 5200 Illumina Way, San Diego, CA 92122.
What is the purpose of an 8-K filing under Item 5.02?
An 8-K filing under Item 5.02 is used to report the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers,' indicating changes in key personnel or their compensation.
Filing Stats: 414 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2024-01-04 17:11:45
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value ILMN NASDAQ Indicate by
Filing Documents
- form8-k.htm (8-K) — 23KB
- image0.jpg (GRAPHIC) — 2KB
- 0000950157-24-000024.txt ( ) — 158KB
- ilmn-20240104.xsd (EX-101.SCH) — 4KB
- ilmn-20240104_lab.xml (EX-101.LAB) — 22KB
- ilmn-20240104_pre.xml (EX-101.PRE) — 16KB
- form8-k_htm.xml (XML) — 4KB
From the Filing
falseIllumina, Inc.0001110803CA00011108032023-08-312023-08-31 [ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2024 Illumina, Inc. (Exact name of registrant as specified in its charter) 001-35406 (Commission File Number) Delaware (State or other jurisdiction of incorporation) 33-0804655 (I.R.S. Employer Identification No.) 5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 ) 202-4500 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ILMN NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 4, 2024, Illumina, Inc. (the "Company") announced that Susan Tousi, Chief Commercial Officer, will be leaving the Company effective as of January 5, 2024, and that Bas Verhoef, Head of Region – Europe, will serve as Interim Chief Commercial Officer. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ILLUMINA, INC. Date: January 4, 2024 By: /s/ Charles E. Dadswell Name: Charles E. Dadswell Title: General Counsel and Secretary